Managing menopausal symptoms in women who have a history of pelvic cancer: Is hormone replacement therapy appropriate?

Abstract

Get full access to this article

View all access options for this article.

References

Hamoda

Mukherjee

Morris

, et al. Joint position statement by the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on best practice recommendations for the care of women experiencing the menopause. Post Reprod Health 2022 0(0) 1–2.

NICE . Shared decision making (NG 197), https://www.nice.org.uk/guidance/ng167

Bray

Ferlay

Soerjomataram

, et al. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cance rs in 185 countries. CA Cancer J Clin 2018; 68(6): 394–424.

Cancer Research UK Cancer Statistics for the UK . https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/uterine-cancer/incidence#heading-One

World Cancer Research Fund/American Institute for Cancer Research . Continuous update project expert report 2018.

Suriano

K.A.

McHale

McLaren

, et al. Estrogen replacement therapy in endometrial cancer patients: A matched control study. Obstet Gynecol (New York 1953) 2001; 97(4): 555–560.

Ayhan

Taskiran

Simsek

, et al.

Does immediate hormone replacement therapy affect the oncologic outcome in endometrial cancer survivors?

Int J Gynecol Cancer 2006; 16(2): 805–808.

Creasman

W.T.

Henderson

Hinshaw

, et al. Estrogen Replacement Therapy in the Patient Treated for Endometrial Cancer. Obstetrics Gynecol (New York 1953) 1986; 67(3): 326–330.

Lee

Burke

Park

. Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol 1990; 36(2): 189–191.

10.

Chapman

DiSaia

Osann

, et al. Estrogen replacement in surgical stage I and II endometrial cancer survivors. Am J Obstet Gynecol 1996; 175(5): 1195–1200.

11.

Poulsen

Jacobsen

Bertelsen

, et al. Adjuvant radiation therapy is not necessary in the management of endometrial carcinoma stage I, low risk cases. Int J Gynecol Cancer 1996; 6: 38–43.

12.

Basakci

Kirkali

Tuzel

, et al. Prognostic significance of estrogen receptor expression in superficial transitional cell carcinoma of the urinary bladder. Eur Urol 2002; 41(3): 342–345.

13.

Deli

Orosz

Jakab

. Hormone replacement therapy in cancer survivors – Review of the literature. Pathol Oncol Res 2020; 26: 63–78.

14.

Uhlig

Hosseini

ASA

Simon

, et al. Gender specific differences in disease-free, cancer specific and overall survival after radical cystectomy for bladder cancer: A systematic review and meta-analysis. J Urol 2018; 200: 48–60.

15.

Modi

Dhillo

. Neurokinin 3 receptor antagonism: A novel treatment for menopausal hot flushes. Neuroendocrinol 2019; 109(3): 242–248.